Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Aronow

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
JACEP|April 1, 1979
Screening by clinical scorecardD Aronow
Health News (Waltham, Mass.)|February 20, 2002
Stent-or-bypass dilemma revisitedH D Aronow
Vascular Medicine (London, England)|December 7, 2022
Presidential Address: Mission-drivenHerbert D Aronow
Vascular Medicine (London, England)|December 13, 2021
SVM Communications: Message from the President - Strength in MembersHerbert D Aronow
Vascular Medicine (London, England)|November 8, 2021
SVM Communications: Highlights from the 32nd SVM Scientific SessionsHerbert D Aronow
Annals of Internal Medicine|December 22, 2010
ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MIHerbert D Aronow
The Journal of Invasive Cardiology|April 6, 2012
Heparin dose and harm: absence of evidence or evidence of absence?Herbert D Aronow
Vascular Medicine (London, England)|April 7, 2021
SVM Communications: Message from the Scientific Program Committee ChairHerbert D Aronow
Vascular Medicine (London, England)|October 18, 2023
Presidential Address: Bigger and betterHerbert D Aronow
Interventional Cardiology Clinics|March 10, 2020
Peripheral Vascular Intervention from Head to Toe: Navigating the TurnsHerbert D Aronow
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
JACEP|April 1, 1979
Screening by clinical scorecardD Aronow
Health News (Waltham, Mass.)|February 20, 2002
Stent-or-bypass dilemma revisitedH D Aronow
Vascular Medicine (London, England)|December 7, 2022
Presidential Address: Mission-drivenHerbert D Aronow
Vascular Medicine (London, England)|December 13, 2021
SVM Communications: Message from the President - Strength in MembersHerbert D Aronow
Vascular Medicine (London, England)|November 8, 2021
SVM Communications: Highlights from the 32nd SVM Scientific SessionsHerbert D Aronow
Annals of Internal Medicine|December 22, 2010
ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MIHerbert D Aronow
The Journal of Invasive Cardiology|April 6, 2012
Heparin dose and harm: absence of evidence or evidence of absence?Herbert D Aronow
Vascular Medicine (London, England)|April 7, 2021
SVM Communications: Message from the Scientific Program Committee ChairHerbert D Aronow
Vascular Medicine (London, England)|October 18, 2023
Presidential Address: Bigger and betterHerbert D Aronow
Interventional Cardiology Clinics|March 10, 2020
Peripheral Vascular Intervention from Head to Toe: Navigating the TurnsHerbert D Aronow
Pageof 27